BSc MS - Cardiovascular Systems Pres Chairman

Insider

BSc MS is Pres Chairman of Cardiovascular Systems
Age 62
Phone651 259 1600
Webhttps://www.csi360.com

Cardiovascular Systems Management Efficiency

The company has return on total asset (ROA) of (0.0756) % which means that it has lost $0.0756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1518) %, meaning that it created substantial loss on money invested by shareholders. Cardiovascular Systems' management efficiency ratios could be used to measure how well Cardiovascular Systems manages its routine affairs as well as how well it operates its assets and liabilities.
Cardiovascular Systems currently holds 22.15 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Cardiovascular Systems has a current ratio of 5.93, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Cardiovascular Systems' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

BA ChemistryOrthofix Medical
63
Heather BrennanEstablishment Labs Holdings
N/A
Sridhar KosarajuNevro Corp
42
Joseph PowersSi Bone
64
Margaret CarthyInteger Holdings Corp
60
Mark SaxtonNeuropace
59
Donald MiddlebrookNevro Corp
69
Marco DolciLivaNova PLC
62
John OrdwaySight Sciences
N/A
Andre MarquetteNeuropace
N/A
Stacey DesrochersBruker
N/A
Julie DeweyNevro Corp
63
Thomas TimbieTreace Medical Concepts
66
Daniel OwensTreace Medical Concepts
52
Tomas NavratilGlaukos Corp
Cenk SumenMaxCyte
50
Brendan ShookParagon 28
N/A
Laverne CouncilCONMED
59
David HaffnerGlaukos Corp
N/A
Salvador DadaEstablishment Labs Holdings
42
Denice TorresGlaukos Corp
60
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota. Cardiovascular Syst operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 725 people. Cardiovascular Systems (CSII) is traded on NASDAQ Exchange in USA and employs 725 people.

Management Performance

Cardiovascular Systems Leadership Team

Elected by the shareholders, the Cardiovascular Systems' board of directors comprises two types of representatives: Cardiovascular Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardiovascular. The board's role is to monitor Cardiovascular Systems' management team and ensure that shareholders' interests are well served. Cardiovascular Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardiovascular Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
Philip Freed, VP Marketing
Stephen Rempe, Chief Officer
Jeffrey MD, Chief Officer
Peter Hirshman, VP Operations
Sandra Sedo, Chief Compliance Officer
Jeffrey Points, Chief Officer
BSc MS, Pres Chairman
Alexander Rosenstein, General Counsel and Corporate Secretary
John Nielsen, VP Communications

Cardiovascular Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardiovascular Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Cardiovascular Stock

If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world